Open Payments

ELIZABETH DEL PRADO TAN-CHIU

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
Where
RUSKIN, FL
NPI
1538113931
Received
$2,490 in 45 records, 2019 to 2025
As principal investigator
$9,682 of research payments to others in 6 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment3$1,434
2024General payment1$13
2023General payment1$27
2022General payment2$135
2021General payment1$116
2020General payment21$454
2019General payment16$309

By company

CompanyRecordsAmountYears
Eli Lilly and Company1$1,2502025
AstraZeneca Pharmaceuticals LP7$2382019–2021
Takeda Pharmaceuticals U.S.A., Inc.3$1362019–2020
Lilly USA, LLC1$1212025
Novocure Inc.1$782022
PFIZER INC.1$632025
Myriad Genetic Laboratories, Inc.1$562022
Novartis Pharmaceuticals Corporation3$532019–2020
GENZYME CORPORATION3$532019–2020
Pharmacyclics LLC, an AbbVie Company2$462019–2023
Celgene Corporation2$412019–2020
Boehringer Ingelheim Pharmaceuticals, Inc.2$382019–2020
E.R. Squibb & Sons, L.L.C.2$352020
Bayer Healthcare Pharmaceuticals Inc.2$342019–2020
EMD Serono, Inc.1$252020
Astellas Pharma US Inc1$242020
Daiichi Sankyo Inc.1$232020
Rigel Pharmaceuticals, Inc.1$222020
Genentech USA, Inc.1$202019
Janssen Biotech, Inc.1$202019
Merck Sharp & Dohme LLC1$182019
EUSA Pharma (US) LLC1$162019
TOLMAR Pharmaceuticals, Inc.1$152020
Agios Pharmaceuticals, Inc.1$152020
Partner Therapeutics, Inc.1$142019
Amgen Inc.1$132024
Secura Bio, Inc.2$132020

By nature of payment

NatureRecordsAmount
Consulting Fee1$1,250
Food and Beverage44$1,240

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-18Eli Lilly and Company$1,250Consulting FeeCash or cash equivalent2025
2025-12-10PFIZER INC.$63Food and BeverageIn-kind items and servicesIBRANCE Drug, ONCOLOGY2025
2025-10-23Lilly USA, LLC$121Food and BeverageIn-kind items and servicesVERZENIO Drug, Oncology2025
2024-02-26Amgen Inc.$13Food and BeverageIn-kind items and servicesTEPEZZA Biological, Inflammation/Rare Disease2024
2023-12-06Pharmacyclics LLC, an AbbVie Company$27Food and BeverageIn-kind items and servicesEPKINLY Drug, ONCOLOGY2023
2022-10-14Novocure Inc.$78Food and BeverageCash or cash equivalentOptune Device, Oncology2022
2022-02-23Myriad Genetic Laboratories, Inc.$56Food and BeverageCash or cash equivalentmyRisk Device, Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis2022
2021-10-13AstraZeneca Pharmaceuticals LP$116Food and BeverageIn-kind items and servicesTAGRISSO Drug, Oncology2021
2020-02-28Novartis Pharmaceuticals Corporation$14Food and BeverageIn-kind items and servicesMEKINIST Drug, ONCOLOGY2020
2020-02-27AstraZeneca Pharmaceuticals LP$19Food and BeverageIn-kind items and servicesLYNPARZA Drug, Oncology2020
2020-02-26AstraZeneca Pharmaceuticals LP$18Food and BeverageIn-kind items and servicesIMFINZI Drug, Oncology2020
2020-02-19Takeda Pharmaceuticals U.S.A., Inc.$92Food and BeverageIn-kind items and servicesNINLARO Drug, ONCOLOGY2020
2020-02-19GENZYME CORPORATION$18Food and BeverageIn-kind items and servicesCABLIVI Biological, Hematology2020
2020-02-10Agios Pharmaceuticals, Inc.$15Food and BeverageCash or cash equivalentTIBSOVO Drug, Oncology2020
2020-02-06TOLMAR Pharmaceuticals, Inc.$15Food and BeverageIn-kind items and servicesELIGARD Drug, Prostate Cancer2020
2020-02-04E.R. Squibb & Sons, L.L.C.$19Food and BeverageCash or cash equivalentOPDIVO Biological, Oncology2020
2020-01-31Boehringer Ingelheim Pharmaceuticals, Inc.$20Food and BeverageIn-kind items and servicesGILOTRIF Drug, ONCOLOGY2020
2020-01-31AstraZeneca Pharmaceuticals LP$17Food and BeverageIn-kind items and servicesIMFINZI Drug, Oncology2020
2020-01-27Daiichi Sankyo Inc.$23Food and BeverageIn-kind items and servicesEnhertu Drug, Oncology2020
2020-01-25E.R. Squibb & Sons, L.L.C.$16Food and BeverageCash or cash equivalentOPDIVO Biological, Oncology2020
2020-01-23EMD Serono, Inc.$25Food and BeverageIn-kind items and servicesBavencio Drug, Oncology2020
2020-01-22Astellas Pharma US Inc$24Food and BeverageIn-kind items and servicesXOSPATA Drug, ONCOLOGY2020
2020-01-21Rigel Pharmaceuticals, Inc.$22Food and BeverageIn-kind items and servicesTavalisse Drug, Hematology2020
2020-01-16GENZYME CORPORATION$19Food and BeverageIn-kind items and servicesCABLIVI Biological, Hematology2020
2020-01-14Celgene Corporation$20Food and BeverageCash or cash equivalentINREBIC Drug, Hematology2020
2020-01-13AstraZeneca Pharmaceuticals LP$20Food and BeverageIn-kind items and servicesLYNPARZA Drug, Oncology2020
2020-01-08Secura Bio, Inc.$13Food and BeverageCash or cash equivalentFarydak Drug, Oral Oncologic2020
2020-01-08Secura Bio, Inc.$0Food and BeverageCash or cash equivalentFarydak Drug, Oral Oncologic2020
2020-01-06Bayer Healthcare Pharmaceuticals Inc.$18Food and BeverageIn-kind items and servicesStivarga Drug, Oncology2020
2019-12-16Pharmacyclics LLC, an AbbVie Company$19Food and BeverageIn-kind items and servicesImbruvica Drug, Oncology2019
2019-12-13Genentech USA, Inc.$20Food and BeverageIn-kind items and servicesTECENTRIQ Biological, BioOncology2019
2019-12-11Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesPROMACTA Drug, ONCOLOGY2019
2019-12-03Novartis Pharmaceuticals Corporation$22Food and BeverageIn-kind items and servicesVOTRIENT Drug, ONCOLOGY2019
2019-12-02GENZYME CORPORATION$15Food and BeverageIn-kind items and servicesCABLIVI Drug, RARE BLOOD DISORDERS2019
2019-11-22Bayer Healthcare Pharmaceuticals Inc.$15Food and BeverageIn-kind items and servicesNexavar Drug, Oncology2019
2019-11-20Partner Therapeutics, Inc.$14Food and BeverageIn-kind items and servicesLeukine Drug, Hematology2019
2019-11-19Celgene Corporation$21Food and BeverageIn-kind items and servicesRevlimid Drug, Hematology / Oncology2019
2019-11-14AstraZeneca Pharmaceuticals LP$26Food and BeverageIn-kind items and servicesLYNPARZA Drug, Oncology2019
2019-11-11EUSA Pharma (US) LLC$16Food and BeverageIn-kind items and servicesSylvant Biological, Hematology Oncology2019
2019-11-07Takeda Pharmaceuticals U.S.A., Inc.$20Food and BeverageIn-kind items and services2019
2019-11-06AstraZeneca Pharmaceuticals LP$19Food and BeverageIn-kind items and servicesIMFINZI Drug, Oncology2019
2019-11-05Janssen Biotech, Inc.$20Food and BeverageIn-kind items and servicesBalversa Drug, Oncology2019
2019-11-04Takeda Pharmaceuticals U.S.A., Inc.$23Food and BeverageIn-kind items and services2019
2019-06-20Boehringer Ingelheim Pharmaceuticals, Inc.$17Food and BeverageIn-kind items and servicesGILOTRIF Drug, ONCOLOGY2019
2019-06-19Merck Sharp & Dohme LLC$18Food and BeverageIn-kind items and servicesKEYTRUDA Biological, ONCOLOGY2019

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2022-02-10Novartis Pharmaceuticals CorporationFLORIDA CANCER RESEARCH INSTITUTE LLC$2,242MONALEESA 3 A RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED STUDY OF RIBOCICLIB IN COMBINATION WITH FULVESTRANT FOR THE TREA2022
2020-11-11Novartis Pharmaceuticals CorporationFLORIDA CANCER RESEARCH INSTITUTE$600TRINITI1 A PHASE I AND OR II SINGLE ARM OPEN LABEL STUDY OF RIBOCICLIB IN COMBINATION WITH EVEROLIMUS PLUS EXEMESTANE IN2020
2020-01-09Novartis Pharmaceuticals CorporationFLORIDA CANCER RESEARCH INSTITUTE$611AN OPEN LABEL MULTICENTER PHASE IIIB STUDY OF RIBOCICLIB LEE011 IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTM2020
2019-06-08PUMA BIOTECHNOLOGY, INC.Florida Cancer Care And Florida Cancer Research Institute$3,160A Randomized, Double-Blind, Placebo-Controlled Trial Of Neratinib2019
2019-05-23Novartis Pharmaceuticals CorporationFLORIDA CANCER RESEARCH INSTITUTE$2,231AN OPEN LABEL MULTICENTER PHASE IIIB STUDY OF RIBOCICLIB LEE011 IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTM2019
2019-04-03Novartis Pharmaceuticals CorporationFLORIDA CANCER RESEARCH INSTITUTE LLC$838MONALEESA 3 A RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED STUDY OF RIBOCICLIB IN COMBINATION WITH FULVESTRANT FOR THE TREA2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Hillsborough CountyRuskin CDP

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Ruskin, FL, county Hillsborough County, FL, state Florida; placed by its city name.

MeasurePlace (city or town)
Ruskin, FL
County
Hillsborough County, FL
State
Florida
Population B0100329,8341,522,74822,416,077
Population, 2020 census P128,6201,459,76221,538,187
Median age B0100235.037.942.6
Under 18 B0100127.5%21.6%19.5%
65 and over B0100111.1%15.0%21.3%
Households B1100110,197583,1928,752,810
Foreign born B0500214.0%19.7%21.9%
Median household income B19013$79,235$79,540$74,568
Median family income B19113$86,726$96,725$89,891
Per capita income B19301$31,968$44,342$42,609
Poverty rate B1700110.8%12.7%12.6%
Unemployment rate B230254.5%4.5%4.8%
Civilian labor force B2302514,790802,80911,016,578
Mean commute (minutes) B0801335.628.828.0
Bachelor's degree or higher B1500322.4%38.1%34.1%
Housing units B2500111,516630,69210,256,470
Owner-occupied B2500375.4%61.5%67.6%
Renters B2500324.6%38.5%32.4%
Median home value B25077$323,000$371,500$359,000
Median gross rent B25064$1,419$1,667$1,669
White, not Hispanic B0300235.3%44.8%50.4%
Black B0300224.2%15.3%14.6%
Hispanic or Latino B0300233.6%30.4%27.4%
Asian B030021.7%4.5%2.9%
American Indian and Alaska Native B030020.0%0.1%0.1%

Economy now FRED unemployment 4.4% in Sep 2026 (4.2% a year earlier); per capita personal income $78,345 in 2025, up 38% in five years (+11.3% after inflation); Unemployment rate: 4.9% in Sep 2016 to 4.4% in Sep 2026; low 2.8%, high 14.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Ruskin, FL.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.